Female libido pill maker Sprout bought by Valeant for $1 billion – PPP Focus.com


PPP Focus.com

Female libido pill maker Sprout bought by Valeant for $1 billion
PPP Focus.com
There has been much talk lately about the potential release of a new female libido drug, but while the main discussion has been about the relevance of the medicine, some discussion must also be underway to identify diagnostic criteria for this drug. It
Controversy dogs female libido drugBDlive
Insurers debate coverage for female libido pillHealthcare Dive
Looks Like Best Week Ever for Maker of Female Libido PillRapid News Network
Lid Time – Weird News, Entertainment, News Headlines (blog) –Yale News
all 166 news articles »

Critics say drugmakers boost sex medicine market with female libido questionnaire – Akron Beacon Journal


ABC News

Critics say drugmakers boost sex medicine market with female libido questionnaire
Akron Beacon Journal
If you're a drugmaker trying to win approval for a medication to boost female libido, it might come down to two questions on a medical questionnaire. Those questions made the difference for Sprout Pharmaceuticals, which received federal approval
Looks Like Best Week Ever for Maker of Female Libido PillABC News
Female libido pill maker Sprout bought by Valeant for $1 billionCNNMoney
Sexy ads for women's libido drug? Maybe not yetCNBC
Bloomberg –Huffington Post
all 1,101 news articles »

Why some doctors are wary of the new female libido pill – PBS NewsHour (blog)


PBS NewsHour (blog)

Why some doctors are wary of the new female libido pill
PBS NewsHour (blog)
Addyi, a new female libido pill, will hit the market this fall, but the prescription drug was twice rejected by the FDA in the past. For a closer look at the uses and risks, Judy Woodruff speaks to Dr. Adriane Fugh-Berman of the Georgetown University

and more »

8 Things You Should Know About The New Female Libido Pill – Huffington Post


Huffington Post

8 Things You Should Know About The New Female Libido Pill
Huffington Post
8 Things You Should Know About The New Female Libido Pill. Experts usually describe Addyi's effect as "modest." Associated Press. By Matthew Perrone. Posted: 08/19/2015 10:46 AM EDT. ASSOCIATED PRESS Share on Pinterest. WASHINGTON (AP) …
Valeant Buys Female Libido-Drug Maker Sprout for $1 BillionBloomberg
Female libido pill maker Sprout bought by Valeant for $1 billionCNNMoney
Valeant to buy female libido drugmaker Sprout for $1 billionCNBC
ABC News –CTV News
all 1,101 news articles »

Can I Take it? And Other Questions About The Female Libido Pill – NBCNews.com


Gizmag

Can I Take it? And Other Questions About The Female Libido Pill
NBCNews.com
Federal health officials have approved the first-ever prescription drug intended to treat women suffering from a lack of sexual desire, ending a vigorous debate over the drug's fate. (0:24). advertisement. advertisement. ${title}. Text Display. Font
FDA ticks off on drug to boost female libidoGizmag
The Female Libido Pill Is Here, But There Isn't Much Evidence It Does AnythingNew York Magazine
Raleigh's Sprout Pharmaceuticals awaits FDA ruling on female libido drugCharlotte Observer
CBC.ca –Chicago Tribune
all 1,302 news articles »

Drug execs behind female libido pill have run afoul of FDA – TBO.com


TBO.com

Drug execs behind female libido pill have run afoul of FDA
TBO.com
Sprout soon may succeed where many of the world's largest pharmaceutical companies have failed: in winning Food and Drug Administration approval for the first drug to boost women's sexual desire. THE ASSOCIATED PRESS. The Associated Press
Drug execs behind female libido pill have run afoul of FDA, but will it matter?Crain’s Detroit Business
Raleigh's Sprout Pharmaceuticals awaits FDA ruling on female libido drugCharlotte Observer
FDA Could Approve First Female Libido Pill SoonU.S. News & World Report

all 27 news articles »

Raleigh’s Sprout Pharmaceuticals awaits FDA ruling on female libido drug – News & Observer


News & Observer

Raleigh's Sprout Pharmaceuticals awaits FDA ruling on female libido drug
News & Observer
The potential U.S. annual sales for female libido drugs is estimated at $2 billion, but it's not clear what slice of that market Sprout would capture. Sprout is seeking FDA approval for its drug to be prescribed to pre-menopausal women with a medical
Drug execs behind female libido pill have run afoul of FDAFox News
FDA mulls approval of female libido pillKXAN.com

all 131 news articles »